HIGHLIGHTS
- who: Riccardo Asero and colleagues from the Clinica San Carlo, Ambulatorio Allergologia, Paderno Dugnano, Milan, Italy have published the article: Thyroid Autoimmunity in CSU: A Potential Marker of Omalizumab Response?, in the Journal: (JOURNAL)
- what: The authors investigated whether the presence of thyroid autoimmunity alone and the level of thyroid peroxidase IgG autoantibodies may be helpful to predict the response to omalizumab in clinical practice, thus discriminating patients with probable severe type I or type IIb CSU.
SUMMARY
The severity of chronic spontaneous urticaria (CSU), a rather frequent disease characterized by . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.